Ancora Advisors’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-14
| Closed | -$1.01K | – | 1817 |
|
|
2023
Q1 | $1.01K | Buy |
+14
| New | +$1.01K | ﹤0.01% | 1589 |
|
|
2021
Q2 | – | Sell |
-240
| Closed | -$23K | – | 1942 |
|
|
2021
Q1 | $23K | Hold |
240
| – | – | ﹤0.01% | 1238 |
|
|
2020
Q4 | $15K | Hold |
240
| – | – | ﹤0.01% | 1098 |
|
|
2020
Q3 | $14K | Hold |
240
| – | – | ﹤0.01% | 1049 |
|
|
2020
Q2 | $17K | Hold |
240
| – | – | ﹤0.01% | 990 |
|
|
2020
Q1 | $11K | Hold |
240
| – | – | ﹤0.01% | 1115 |
|
|
2019
Q4 | $16K | Buy |
+240
| New | +$16K | ﹤0.01% | 1078 |
|
|
2018
Q4 | – | Sell |
-240
| Closed | -$41K | – | 954 |
|
|
2018
Q3 | $41K | Buy |
+240
| New | +$41K | ﹤0.01% | 934 |
|
|
2017
Q1 | – | Sell |
-240
| Closed | -$15K | – | 884 |
|
|
2016
Q4 | $15K | Buy |
+240
| New | +$15K | ﹤0.01% | 991 |
|